{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:31Z","timestamp":1787166511337,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Development Program of China","award":["NO: 2020YFC2008302"],"award-info":[{"award-number":["NO: 2020YFC2008302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11096-022-01397-5","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:48:09Z","timestamp":1648831689000},"page":"709-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data"],"prefix":"10.1007","volume":"44","author":[{"given":"Chunyan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-5193","authenticated-orcid":false,"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"1","key":"1397_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"M Leise","year":"2014","unstructured":"Leise M, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89(1):95\u2013106.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1397_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/jhep.2002.34857","volume":"36","author":"C Sgro","year":"2002","unstructured":"Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. 2002;36(2):451\u20135.","journal-title":"Hepatology"},{"issue":"7","key":"1397_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","volume":"144","author":"ES Bj\u00f6rnsson","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419\u201325 (25.e1-3; quiz e19-20).","journal-title":"Gastroenterology"},{"issue":"8","key":"1397_CR4","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland China. Gastroenterology. 2019;156(8):2230-41.e11.","journal-title":"Gastroenterology"},{"issue":"2","key":"1397_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/ijms17020224","volume":"17","author":"ES Bj\u00f6rnsson","year":"2016","unstructured":"Bj\u00f6rnsson ES. Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci. 2016;17(2):224.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1397_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340-52.e7.","journal-title":"Gastroenterology"},{"issue":"10","key":"1397_CR7","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.21037\/jtd.2017.09.75","volume":"9","author":"YD Yin","year":"2017","unstructured":"Yin YD, Wang R, Zhuo C, et al. Macrolide-resistant Mycoplasma pneumoniae prevalence and clinical aspects in adult patients with community-acquired pneumonia in China: a prospective multicenter surveillance study. J Thorac Dis. 2017;9(10):3774\u201381.","journal-title":"J Thorac Dis"},{"issue":"11","key":"1397_CR8","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.21037\/tp-21-356","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen J, Qi X, Yin Y, et al. Effects of minocycline on macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a single-center retrospective study. Transl Pediatr. 2021;10(11):2997\u20133004.","journal-title":"Transl Pediatr"},{"issue":"2","key":"1397_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/antibiotics10020192","volume":"10","author":"H Lee","year":"2021","unstructured":"Lee H, Choi YY, Sohn YJ, et al. Clinical efficacy of doxycycline for treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Antibiotics (Basel). 2021;10(2):192.","journal-title":"Antibiotics (Basel)."},{"issue":"6","key":"1397_CR10","first-page":"619","volume":"12","author":"AL Zaenglein","year":"2013","unstructured":"Zaenglein AL, Shamban A, Webster G, et al. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. J Drugs Dermatol. 2013;12(6):619\u201325.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"1397_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40257-017-0267-z","volume":"18","author":"A Bienenfeld","year":"2017","unstructured":"Bienenfeld A, Nagler AR, Orlow SJ. Oral antibacterial therapy for acne vulgaris: an evidence-based review. Am J Clin Dermatol. 2017;18(4):469\u201390.","journal-title":"Am J Clin Dermatol"},{"issue":"20","key":"1397_CR12","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2021.17633","volume":"326","author":"DZ Eichenfield","year":"2021","unstructured":"Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA-J Am Med Assoc. 2021;326(20):2055\u201367.","journal-title":"JAMA-J Am Med Assoc"},{"issue":"11","key":"1397_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/1060028019863796","volume":"53","author":"JS Stultz","year":"2019","unstructured":"Stultz JS, Eiland LS. Doxycycline and tooth discoloration in children: changing of recommendations based on evidence of safety. Ann Pharmacother. 2019;53(11):1162\u20136.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1397_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","volume":"64","author":"GG Zhanel","year":"2004","unstructured":"Zhanel GG, Homenuik K, Nichol K, et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs. 2004;64(1):63.","journal-title":"Drugs"},{"issue":"6","key":"1397_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s15010-020-01520-6","volume":"48","author":"S Karakonstantis","year":"2020","unstructured":"Karakonstantis S, Kritsotakis EI, Gikas A. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection. 2020;48(6):835\u201351.","journal-title":"Infection"},{"issue":"12","key":"1397_CR16","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1093\/jac\/dkz337","volume":"74","author":"H Mei","year":"2019","unstructured":"Mei H, Yang T, Wang J, et al. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis. J Antimicrob Chemoth. 2019;74(12):3423\u201331.","journal-title":"J Antimicrob Chemoth"},{"issue":"1","key":"1397_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/sur.2006.7.69","volume":"7","author":"MH Wilcox","year":"2006","unstructured":"Wilcox MH. Tigecycline and the need for a new broad-spectrum antibiotic class. Surg Infect. 2006;7(1):69\u201380.","journal-title":"Surg Infect"},{"issue":"Supplement-1","key":"1397_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1179\/joc.2009.21.Supplement-1.56","volume":"21","author":"S Esposito","year":"2009","unstructured":"Esposito S, Petta E. Tigecycline for treatment of intra-abdominal infections: a literature update. J Chemother. 2009;21(Supplement-1):56\u201360.","journal-title":"J Chemother"},{"issue":"Suppl 1","key":"1397_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jgar.2021.04.006","volume":"25","author":"B Leng","year":"2021","unstructured":"Leng B, Yan G, Wang C, et al. Dose optimization based on pharmacokinetic\/pharmacodynamic target of tigecycline. J Glob Antimicrob Resist. 2021;25(Suppl 1):315\u201322.","journal-title":"J Glob Antimicrob Resist"},{"key":"1397_CR20","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.2147\/IDR.S322803","volume":"14","author":"H Han","year":"2021","unstructured":"Han H, Qin W, Zheng Y, et al. High-dose versus standard-dose tigecycline treatment of secondary bloodstream infections caused by extensively drug-resistant Acinetobacter baumannii: an observational cohort study. Infect Drug Resist. 2021;14:3837\u201348.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"1397_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2133.2012.10845.x","volume":"166","author":"B Lebrun-Vignes","year":"2012","unstructured":"Lebrun-Vignes B, Kreft-Jais C, Castot A, et al. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Brit J Dermatol. 2012;166(6):1333\u201341.","journal-title":"Brit J Dermatol"},{"issue":"9","key":"1397_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K Smith","year":"2005","unstructured":"Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther. 2005;27(9):1329\u201342.","journal-title":"Clin Ther"},{"key":"1397_CR23","unstructured":"Bettesda(MD). Liver Tox: Clinical and research information on drug-induced liver injury. PubMed. 2019; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548040\/. Last update: 10 April 2019."},{"issue":"1","key":"1397_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0002-9378(66)90623-5","volume":"95","author":"ES Allen","year":"1966","unstructured":"Allen ES, Brown WE. Hepatic toxicity of tetracycline in pregnancy. Am J Obstet Gynecol. 1966;95(1):12\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"1397_CR25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/0002-9610(67)90308-X","volume":"113","author":"RL Peters","year":"1967","unstructured":"Peters RL, Edmondson HA, Mikkelsen WP, et al. Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. Am J Surg. 1967;113(5):622\u201332.","journal-title":"Am J Surg"},{"issue":"38","key":"1397_CR26","doi-asserted-by":"publisher","first-page":"e12467","DOI":"10.1097\/MD.0000000000012467","volume":"97","author":"Z Chen","year":"2018","unstructured":"Chen Z, Shi X. Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens. Medicine (Baltimore). 2018;97(38):e12467.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1397_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/00365520510023846","volume":"40","author":"E Bj\u00f6rnsson","year":"2005","unstructured":"Bj\u00f6rnsson E, Jerlstad P, Bergqvist A, et al. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40(9):1095\u2013101.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"1397_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","volume":"32","author":"PC Heaton","year":"2007","unstructured":"Heaton PC, Fenwick SR, Brewer DE. Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study. J Clin Pharm Ther. 2007;32(5):483\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"1397_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","volume":"10","author":"CC Sheu","year":"2019","unstructured":"Sheu CC, Chang YT, Lin SY, et al. Infections caused by Carbapenem-resistant enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80.","journal-title":"Front Microbiol"},{"issue":"10","key":"1397_CR30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/1389200219666180427165035","volume":"19","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Annaert P. Drug-induced cholestasis: mechanisms, models, and markers. Curr Drug Metab. 2018;19(10):808\u201318.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"1397_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1397_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1397_CR33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jamia\/ocv063","volume":"23","author":"HJ Duggirala","year":"2016","unstructured":"Duggirala HJ, Tonning JM, Smith E, et al. Use of data mining at the Food and Drug Administration. J Am Med Inform Assn. 2016;23(2):428\u201334.","journal-title":"J Am Med Inform Assn"},{"key":"1397_CR34","unstructured":"FDA. FDA adverse event reporting system (FAERS) quarterly data extract files. 2021; https:\/\/fis.fda.gov\/extensions\/FPD-QDE-FAERS\/FPD-QDE-FAERS.html. Accessed 29 Jan 2021."},{"key":"1397_CR35","first-page":"1989","volume":"39","author":"WU Bin","year":"2019","unstructured":"Bin WU, Feng-Bo WU, Luo M, et al. Application of MedEx in FAERS drug names standardization. China J Hosp Pharm. 2019;39:1989\u201392.","journal-title":"China J Hosp Pharm"},{"issue":"1","key":"1397_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1197\/jamia.M3378","volume":"17","author":"H Xu","year":"2010","unstructured":"Xu H, Stenner SP, Doan S, et al. MedEx: a medication information extraction system for clinical narratives. J Am Med Inform Assoc. 2010;17(1):19\u201324.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"1397_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.yrtph.2015.05.004","volume":"72","author":"A Suzuki","year":"2015","unstructured":"Suzuki A, Yuen NA, Ilic K, et al. Comedications alter drug-induced liver injury reporting frequency: data mining in the WHO VigiBase\u2122. Regul Toxicol Pharmacol. 2015;72(3):481\u201390.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"1397_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.yrtph.2014.09.007","volume":"70","author":"CM Hunt","year":"2014","unstructured":"Hunt CM, Yuen NA, Stirnadel-Farrant HA, et al. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul Toxicol Pharmacol. 2014;70(2):519\u201326.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1397_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jama.1964.03060290111037","volume":"188","author":"HF Dowling","year":"1964","unstructured":"Dowling HF, Lepper MH. Hepatic reactions to tetracycline. JAMA-J Am Med Assoc. 1964;188:307\u20139.","journal-title":"JAMA-J Am Med Assoc"},{"key":"1397_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJM196311072691903","volume":"269","author":"JC Schultz","year":"1963","unstructured":"Schultz JC, Adamson JS Jr, Workman WW, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. New Engl J Med. 1963;269:999\u20131004.","journal-title":"New Engl J Med"},{"issue":"4","key":"1397_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00002018-200023040-00006","volume":"23","author":"RA Lawrenson","year":"2000","unstructured":"Lawrenson RA, Seaman HE, Sundstr\u00f6m A, et al. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Drug Saf. 2000;23(4):333\u201349.","journal-title":"Drug Saf"},{"issue":"10","key":"1397_CR42","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1111\/j.1572-0241.2000.03222.x","volume":"95","author":"HH Nietsch","year":"2000","unstructured":"Nietsch HH, Libman BS, Pansze TW, et al. Minocycline-induced hepatitis. Am J Gastroenterol. 2000;95(10):2993\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1397_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2165\/00003495-200565100-00002","volume":"65","author":"E Rubinstein","year":"2005","unstructured":"Rubinstein E, Vaughan D. Tigecycline: a novel glycylcycline. Drugs. 2005;65(10):1317\u201336.","journal-title":"Drugs"},{"issue":"5","key":"1397_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijid.2005.05.003","volume":"9","author":"S Sacchidanand","year":"2005","unstructured":"Sacchidanand S, Penn RL, Embil JM, et al. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial. Int J Infect Dis. 2005;9(5):251\u201361.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"1397_CR45","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","volume":"11","author":"E Tasina","year":"2011","unstructured":"Tasina E, Haidich AB, Kokkali S, et al. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect Dis. 2011;11(11):834\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1397_CR46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1248\/bpb.35.967","volume":"35","author":"K Kadoyama","year":"2012","unstructured":"Kadoyama K, Sakaeda T, Tamon A, et al. Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system. Biol Pharm Bull. 2012;35(6):967\u201370.","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"1397_CR47","doi-asserted-by":"publisher","first-page":"e02273","DOI":"10.1128\/AAC.02273-17","volume":"62","author":"A Borsuk-De Moor","year":"2018","unstructured":"Borsuk-De Moor A, Rypulak E, Potr\u0119\u0107 B, et al. Population pharmacokinetics of high-dose tigecycline in patients with sepsis or septic shock. Antimicrob Agents Chemother. 2018;62(4):e02273-e2317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1397_CR48","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","volume":"37","author":"L Zha","year":"2020","unstructured":"Zha L, Pan L, Guo J, et al. Effectiveness and safety of high dose tigecycline for the treatment of severe infections: a systematic review and meta-analysis. Adv Ther. 2020;37(3):1049\u201364.","journal-title":"Adv Ther"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-022-01397-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:46:21Z","timestamp":1655293581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-022-01397-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1007\/s11096-022-01397-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}